Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder.

Jenike MA, Baer L, Minichiello WE, Rauch SL, Buttolph ML.

Am J Psychiatry. 1997 Sep;154(9):1261-4.

PMID:
9286186
2.

Fluoxetine versus phenelzine in obsessive-compulsive disorder.

Golwyn DH, Sevlie CP.

Am J Psychiatry. 1999 Jan;156(1):159-60. No abstract available.

PMID:
9892321
3.

Fluoxetine versus phenelzine in atypical depression.

Pande AC, Birkett M, Fechner-Bates S, Haskett RF, Greden JF.

Biol Psychiatry. 1996 Nov 15;40(10):1017-20.

PMID:
8915561
4.

Treatment outcome of obsessive compulsive disorder with comorbid social phobia.

Carrasco JL, Hollander E, Schneier FR, Liebowitz MR.

J Clin Psychiatry. 1992 Nov;53(11):387-91.

PMID:
1459968
5.
6.

Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.

Jarrett RB, Schaffer M, McIntire D, Witt-Browder A, Kraft D, Risser RC.

Arch Gen Psychiatry. 1999 May;56(5):431-7.

7.

Effect of comorbid tics on a clinically meaningful response to 8-week open-label trial of fluoxetine in obsessive compulsive disorder.

Husted DS, Shapira NA, Murphy TK, Mann GD, Ward HE, Goodman WK.

J Psychiatr Res. 2007 Apr-Jun;41(3-4):332-7.

PMID:
16860338
8.

Preschool children with obsessive-compulsive disorder and fluoxetine treatment.

Ercan ES, Kandulu R, Akyol Ardic U.

Eur Child Adolesc Psychiatry. 2012 Mar;21(3):169-72. doi: 10.1007/s00787-012-0244-2.

PMID:
22271063
9.

Clinical predictors of long-term outcome in obsessive-compulsive disorder.

Jakubovski E, Diniz JB, Valerio C, Fossaluza V, Belotto-Silva C, Gorenstein C, Miguel E, Shavitt RG.

Depress Anxiety. 2013 Aug;30(8):763-72. doi: 10.1002/da.22013.

PMID:
23109056
10.

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.

Geller DA, Hoog SL, Heiligenstein JH, Ricardi RK, Tamura R, Kluszynski S, Jacobson JG; Fluoxetine Pediatric OCD Study Team..

J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):773-9.

PMID:
11437015
11.

A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.

McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH.

Arch Gen Psychiatry. 2000 Aug;57(8):794-801.

PMID:
10920469
12.
13.

Efficacy of fluoxetine in Austrian patients with obsessive-compulsive disorder.

Zitterl W, Meszaros K, Hornik K, Twaroch T, Dossenbach M, Zitterl-Eglseer K, Zapotoczky HG.

Wien Klin Wochenschr. 1999 Jun 4;111(11):439-42.

PMID:
10420495
14.

Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.

Tollefson GD, Birkett M, Koran L, Genduso L.

J Clin Psychiatry. 1994 Oct;55 Suppl:69-76; discussion 77-8.

PMID:
7961535
15.

A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).

Alaghband-Rad J, Hakimshooshtary M.

Eur Child Adolesc Psychiatry. 2009 Mar;18(3):131-5. doi: 10.1007/s00787-007-0634-z.

PMID:
19190958
16.

Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo.

Romano S, Goodman W, Tamura R, Gonzales J.

J Clin Psychopharmacol. 2001 Feb;21(1):46-52.

PMID:
11199947
17.
18.

High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.

Ninan PT, Koran LM, Kiev A, Davidson JR, Rasmussen SA, Zajecka JM, Robinson DG, Crits-Christoph P, Mandel FS, Austin C.

J Clin Psychiatry. 2006 Jan;67(1):15-22.

PMID:
16426083
19.

Fluoxetine in children and adolescents with OCD: a placebo-controlled trial.

Liebowitz MR, Turner SM, Piacentini J, Beidel DC, Clarvit SR, Davies SO, Graae F, Jaffer M, Lin SH, Sallee FR, Schmidt AB, Simpson HB.

J Am Acad Child Adolesc Psychiatry. 2002 Dec;41(12):1431-8.

PMID:
12447029
20.

Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.

Vallejo J, Olivares J, Marcos T, Bulbena A, Menchón JM.

Br J Psychiatry. 1992 Nov;161:665-70.

PMID:
1422616
Items per page

Supplemental Content

Support Center